Want a raise, pharma reps? Get into biotech sales instead

Tracy Staton We regularly dig into compensation for top executives, but figures on the biopharma rank and file are harder to come by. So, if you've been waiting for those numbers, ...

Spinal Tap: Reviews Question Benefit Of Medtronic Spinal Product

esilverman As the result of an unusual effort designed to bolster transparency in clinical trials, two independent analyses have found that a Medtronic product used as a bone ...

Royalty’s $8B offer wilts after Elan prevails in blocking bid

Ryan McBride Royalty Pharma signed the death certificate on its $ 8 billion bid for biotech Elan, withdrawing its appeal of a decision from an Irish panel that blocked its ability ...

Omnio iPad app’s power to be unleashed via Physicians Interactive and docwise partnering

mia.burns By Mia Burns Physicians Interactive has entered a partnership with the social magazine docwise to release the power of customized digital content for medical professionals ...

Buzz on rare disease drugs puts ViroPharma in the M&A spotlight

John Carroll ViroPharma's pipeline of drugs for rare diseases has reportedly stirred the interest of several pharma companies. And once word of the buyout buzz spread the Exton, ...

Takeda Diabetes Drugs Launched in U.S.

barbara.lempert Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are ...

AstraZeneca picks Cambridge site as ground zero for R&D reinvention

John Carroll Over the next three years the pharma company plans to build a $ 500 million complex on its new campus that will house its U.K. operations for biologics and small molecule ...

Mendor Announces CE Marking for its Diabetes Management Platform

barbara.lempert ESPOO, Finland, June 18, 2013 /PRNewswire/ — Finnish diabetes technology company Mendor announces today the CE mark for its groundbreaking diabetes management ...

U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis

barbara.lempert PARSIPPANY, N.J., June 17, 2013 /PRNewswire/ — Actavis, Inc. (NYSE: ACT) today announced that the United States Supreme Court has reversed the decision of the ...

Supreme Court Rules Drugmakers Can Be Sued For Pay-To-Delay Deals

esilverman After years of anticipation and considerable debate, the US Supreme Court has ruled that drugmakers can face lawsuits over so-called pay-to-delay patent settlements, ...

Codman Neuro Obtains CE Mark for Enhanced Revive Se Thrombectomy Device

barbara.lempert Self-Expanding Clot Removal Device for Ischemic Stroke Features Newly Enhanced Navigation PARIS, FRANCE– JUNE 13, 2013 – Codman Neuro*, part of DePuy Synthes ...

Opioid Dependence Survey Fact Sheet

mia.burns Opioid Dependence U.S. General Population and Primary Care Doctor Survey Fact Sheet   Opioid dependence (OD; addiction) is more common than many people realize and can ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS